NCT00507260
- Conditions
- Fatigue, Hematologic Diseases, Hemic and Lymphatic Diseases, +13 more
- Locations
-
- University of Texas MD Anderson Cancer Center Houston, Texas, United States
Clinical trial condition
Lymphatic Diseases
Explore clinical trials studying Lymphatic Diseases. Study availability and eligibility vary by location and protocol.
8,990 public trials
1,836 recruiting studies
Lymphatic Diseases trial results
NCT00082784
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue, +33 more
- Locations
-
- Moffitt Cancer Center Tampa, Florida, United States
- University of Pittsburgh Cancer Institute Pittsburgh, Pennsylvania, United States
- University of Pittsburgh Pittsburgh, Pennsylvania, United States
- Medical University of South Carolina Charleston, South Carolina, United States
NCT00078637
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +6 more
- Locations
-
- San Antonio, Texas, United States
Completed
Belinostat and Azacitidine in Treating Patients With Advanced Hematologic Cancers or Other Diseases
NCT00351975
- Conditions
- Accelerated Phase of Disease, Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11, Adult Acute Myeloid Leukemia With t(16;16)(p13.1;q22); CBFB-MYH11, +47 more
- Locations
-
- University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States
- University of Wisconsin Hospital and Clinics Madison, Wisconsin, United States
- University Health Network-Princess Margaret Hospital Toronto, Ontario, Canada
- Princess Margaret Hospital Cashmere, Canterbury, New Zealand
NCT01026415
- Conditions
- Carcinoma, Carcinomas, Disease, Hodgkin, +14 more
- Locations
-
- City of Hope Duarte, California, United States
- Colorado Blood Cancer Institute Denver, Colorado, United States
- St. Francis Medical Group Oncology & Hematology Specialists Indianapolis, Indiana, United States
- Karmanos Cancer Institute / Wayne State University Detroit, Michigan, United States
Completed
Study of SGN-30 (Anti-CD30 mAb) in Patients With Primary Cutaneous Anaplastic Large Cell Lymphoma
NCT00099255
- Conditions
- Dendritic Cell Sarcoma, Interdigitating, Hemic and Lymphatic Diseases, Histiocytic Disorders, Malignant, +14 more
- Locations
-
- University of Alabama at Birmingham Birmingham, Alabama, United States
- University of California at Los Angeles Los Angeles, California, United States
- Stanford University Stanford, California, United States
- Yale New Haven, Connecticut, United States
NCT01015911
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +20 more
- Locations
-
- University of Alabama at Birmingham Birmingham, Alabama, United States
- City of Hope National Medical Center Duarte, California, United States
- UCLA Medical Center / University of California at Los Angeles Los Angeles, California, United States
- Karmanos Cancer Institute / Wayne State University Detroit, Michigan, United States
Completed
Phase I Open-Label Dose Finding Study of SGN-35 for CD30 Positive Hematologic Malignancies
NCT00430846
- Conditions
- Disease, Hodgkin, Hematologic Diseases, Hemic and Lymphatic Diseases, +11 more
- Locations
-
- University of Alabama at Birmingham Birmingham, Alabama, United States
- Washington University St Louis, Missouri, United States
- Weill Cornell Medical College New York, United States
- University of Texas/MD Anderson Cancer Center Houston, Texas, United States
NCT00079716
- Conditions
- Blood Coagulation Disorders, Blood Protein Disorders, Cardiovascular Diseases, +14 more
- Locations
-
- James R. Berenson M.D., Inc. West Hollywood, California, United States
- Rocky Mountain Cancer Center Denver, Colorado, United States
- Dana Farber Cancer Institute Boston, Massachusetts, United States
- Cornell University New York, United States
Completed
A Phase 1 Study of Brentuximab Vedotin Combined With Multi-Agent Chemotherapy for Hodgkin Lymphoma
NCT01060904
- Conditions
- Disease, Hodgkin, Hematologic Diseases, Hemic and Lymphatic Diseases, +8 more
- Locations
-
- Mayo Clinic Rochester, Minnesota, United States
- UNC Lineberger Comprehensive Cancer Center / University of North Carolina Chapel Hill, North Carolina, United States
- MD Anderson Cancer Center / University of Texas Houston, Texas, United States
- British Columbia Cancer Agency - Vancouver Centre Vancouver, British Columbia, Canada